From: Omalizumab: Practical considerations regarding the risk of anaphylaxis
Timing of the reaction | Number of Episodes | ||
---|---|---|---|
 | 1 st , 2 nd or 3 rd Omalizumab dose, n | 4 th Omalizumab dose or later, n (%) | Total |
< 30 minutes | 11 | 5 | 16 |
30 - 60 minutes | 6 | 1 | 7 |
1 - 2 hours | 5 | 0 | 5 |
Total 0 - 2 hours | 22 | 6 | 28 |
2 - 12 hours | 4 | 1 | 5 |
> 12 hours | 3 | 0 | 3 |
Overall Total | 29 | 7 | 36 |